Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.

Isolation of mononuclear cells and granulocytes from human blood.

1968 • 9,672 citations

Regulation of the mevalonate pathway

1990 • 5,282 citations

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

1968 • 5,084 citations

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

1957 • 3,280 citations

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

1986 • 1,989 citations

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

1988 • 760 citations

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

1990 • 203 citations

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

1986 • 157 citations

A NEW INSTRUMENT FOR THE MEASUREMENT OF PLASMA-VISCOSITY

1963 • 103 citations

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects

1982 • 103 citations

Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia

1988 • 79 citations

Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients

1988 • 55 citations

Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia

1988 • 50 citations

Measurement of human leukocyte microsomal HMG-CoA reductase activity.

1984 • 41 citations

The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia

1990 • 39 citations

Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.

1989 • 24 citations

Changes induced by gemfibrozil on lipidic, coagulative and fibrinolytic pattern in patients with type IV hyperlipoproteinemia.

1988 • 24 citations

Modulation of rat liver 3-hydroxy-3-methylglutaryl-CoA reductase activity by reversible phosphorylation.

1982 • 21 citations

Biochemistry and Clinical Significance of Lipoprotein (a)

1988 • 18 citations